Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
复制标题
两种大鼠肺动脉高压模型中右室重构的转录转录分析:人右室衰竭中上皮向间充质转变的识别和验证。
DOI:
10.1161/circheartfailure.120.007058
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Umar S
中科院分区:
文献类型:
--
作者:
Park JF;Clark VR;Banerjee S;Hong J;Razee A;Williams T;Fishbein G;Saddic L;Umar S
Right ventricular (RV) dysfunction is a significant prognostic determinant of morbidity and mortality in pulmonary arterial hypertension (PAH). Despite the importance of RV function in PAH, the underlying molecular mechanisms of RV dysfunction secondary to PAH remain unclear. We aim to identify and compare molecular determinants of RV failure using RNA-sequencing of RV tissue from two clinically relevant animal models of PAH. We performed RNA-sequencing on RV from rats treated with monocrotaline (MCT) or Sugen with hypoxia/normoxia (SuHx). PAH and RV failure were confirmed by catheterization and echocardiography. We validated the RV transcriptome results using quantitative real-time PCR, immunofluorescence and Western blot. Immunohistochemistry and immunofluorescence were performed on human RV tissue from control (n=3) and PAH-induced RV failure patients (n=5). We identified similar transcriptomic profiles of RV from MCT- and SuHx-induced RV-failure. Pathway analysis showed genes enriched in epithelial-to-mesenchymal transition (EMT), inflammation, and metabolism. Histological staining of human RV tissue from patients with RV-failure secondary to PAH revealed significant RV fibrosis and endothelial-to-mesenchymal transition (EndMT), as well as elevated CCN2 (top gene implicated in EMT/EndMT) expression in perivascular areas compared to normal RV. Transcriptomic signature of RV failure in MCT and SuHx models showed similar gene expressions and biological pathways. We provide translational relevance of this transcriptomic signature using RV from PAH patients to demonstrate evidence of EMT/EndMT and protein expression of CCN2 (CTGF). Targeting specific molecular mechanisms responsible for RV failure in MCT and SuHx models may identify novel therapeutic strategies for PAH-associated RV failure.